UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese

Journal of gastroenterology and hepatology, 2012-10, Vol.27 (10), p.1555-1560

Liu, Chun-Jen

2012

Volltextzugriff (PDF)

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.70-85

2018

Volltextzugriff (PDF)

Editorial: Tenofovir disoproxil fumarate more than an antiviral drug—Another piece of the puzzle. Authors' reply

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.289-290

2024

Volltextzugriff (PDF)

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J

Seminars in liver disease, 2013-05, Vol.33 (2), p.97-102

2013

Volltextzugriff (PDF)

Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV

Liver international, 2022-08, Vol.42 (9), p.1945-1954

2022

Volltextzugriff (PDF)

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg‐negative chronic hepatitis B

Hepatology (Baltimore, Md.), 2018-08, Vol.68 (2), p.415-424

2018

Volltextzugriff (PDF)

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.1140-1149.e3

2012

Volltextzugriff (PDF)

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.86-98

2018

Volltextzugriff (PDF)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead

Viruses, 2020-07, Vol.12 (8), p.815

2020

Volltextzugriff (PDF)

Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals

Journal of hepatology, 2020-05, Vol.72 (5), p.839-846

2020

Volltextzugriff (PDF)

Hepatitis C Virus and Hepatitis B Virus Co-Infection

Viruses, 2020-07, Vol.12 (7), p.741

2020

Volltextzugriff (PDF)

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

Hepatology (Baltimore, Md.), 2013-02, Vol.57 (2), p.441-450

2013

Volltextzugriff (PDF)

Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan

Gastroenterology (New York, N.Y. 1943), 2008-07, Vol.135 (1), p.111-121

2008

Volltextzugriff (PDF)

Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load

Alimentary pharmacology & therapeutics, 2021-04, Vol.53 (8), p.908-918

2021

Volltextzugriff (PDF)

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.230-238

2024

Volltextzugriff (PDF)

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping

Journal of medical virology, 2024-05, Vol.96 (5), p.e29686-n/a

2024

Volltextzugriff (PDF)

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

JNCI : Journal of the National Cancer Institute, 2009-10, Vol.101 (19), p.1348-1355

2009

Volltextzugriff (PDF)

Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1407

2022

Volltextzugriff (PDF)

Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues

Journal of gastroenterology and hepatology, 2014-01, Vol.29 (1), p.26-30

Liu, Chun-Jen

2014

Volltextzugriff (PDF)

Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection

The Journal of clinical investigation, 2020-06, Vol.130 (6), p.3205-3220

2020

Volltextzugriff (PDF)

A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B

Liver international, 2023-01, Vol.43 (1), p.77-89

2023

Volltextzugriff (PDF)

Chronic hepatitis B is associated with an increased risk of B‐cell non‐Hodgkin's lymphoma and multiple myeloma

Alimentary pharmacology & therapeutics, 2019-03, Vol.49 (5), p.589-598

2019

Volltextzugriff (PDF)

Serum RNase L levels in patients with chronic hepatitis B virus infection

Hepatology research, 2024-03, Vol.54 (3), p.244-251

2024

Volltextzugriff (PDF)

Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism

Movement disorders, 2019-12, Vol.34 (12), p.1882-1890

2019

Volltextzugriff (PDF)

Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase

Hepatology (Baltimore, Md.), 2019-04, Vol.69 (4), p.1412-1425

2019

Volltextzugriff (PDF)

1 – 25 von 696

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(636)
Mit Volltextzugriff
(644)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(42)
Journal Of The Formosan Medical Association
(36)
Journal Of Gastroenterology And Hepatology
(33)
Hepatology
(30)
Hepatology International
(25)
Liver International
(19)
Gastroenterology
(17)
Antiviral Therapy
(15)
Plos One
(15)
The Journal Of Infectious Diseases
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

Editorial: Tenofovir disoproxil fumarate more than an antiviral drug—Another piece of the puzzle. Authors' reply

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J

Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg‐negative chronic hepatitis B

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead

Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals

Hepatitis C Virus and Hepatitis B Virus Co-Infection

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan

Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines

Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues

Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection

A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B

Chronic hepatitis B is associated with an increased risk of B‐cell non‐Hodgkin's lymphoma and multiple myeloma

Serum RNase L levels in patients with chronic hepatitis B virus infection

Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism

Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase

Suchergebnisse filtern